The Role of Endothelial Glycocalyx in Kidney Transplantation
Launched by CHARLES UNIVERSITY, CZECH REPUBLIC · Dec 13, 2022
Trial Information
Current as of January 13, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a part of the blood vessel lining called the endothelial glycocalyx (EG) and its role in kidney transplantation. Researchers want to learn more about how EG breaks down before and after a kidney transplant by checking blood and urine samples from both the kidney donors and the recipients. They will also use a special imaging technique to visualize the EG directly. The goal is to better understand how EG affects kidney transplants and why it is important.
To participate in this study, you need to be someone who is undergoing a kidney transplant. The trial is open to all genders, and the only requirement is that you must agree to participate by signing an informed consent form. If you join the study, you can expect to have your blood and urine tested, and you may undergo some imaging procedures to help researchers gather important information. This study is currently recruiting participants, so if you or someone you know is considering a kidney transplant, this could be an opportunity to contribute to important research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing kidney transplantation
- Exclusion Criteria:
- • Patients who don't sign the informed consent
About Charles University, Czech Republic
Charles University, located in the Czech Republic, is a prestigious institution renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive academic expertise and state-of-the-art facilities to conduct innovative research that aims to improve patient outcomes and contribute to the global medical community. With a focus on ethical standards and rigorous scientific methodologies, Charles University collaborates with various stakeholders to explore new therapies and enhance healthcare practices, fostering a culture of excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hradec Králové, Czech Republic, Czechia
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials